Bay Harbor Wealth Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bay Harbor Wealth Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-23	Closed	-$3K	–	209
2022 Q4	$3K	Sell	23 -5	-18%	-$415	﹤0.01%	155
2022 Q3	$2K	Sell	28 -918	-97%	-$64.1K	﹤0.01%	180
2022 Q2	$75K	Buy	946 +5	+0.5%	+$473	0.03%	64
2022 Q1	$99K	Hold	941	–	–	0.04%	49
2021 Q4	$88K	Buy	941 +42	+5%	+$4.58K	0.04%	72
2021 Q3	$98K	Sell	899 -11	-1%	-$1.14K	0.04%	61
2021 Q2	$85K	Hold	910	–	–	0.04%	85
2021 Q1	$84K	Buy	910 +878	+2,744%	+$74.1K	0.04%	79
2020 Q4	$2K	Hold	32	–	–	﹤0.01%	364
2020 Q3	$2K	Buy	+32	New	+$2.2K	﹤0.01%	330

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bay Harbor Wealth Management's HZNP Position: Q1 2023 in Review

Bay Harbor Wealth Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 23 shares — an estimated $3K sold.

Bay Harbor Wealth Management first reported a position in HZNP in Q3 2020 and held it in 10 quarters. The position peaked at $99K in Q1 2022. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

Bay Harbor Wealth Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Bay Harbor Wealth Management sold 23 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $3K.
Bay Harbor Wealth Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2020 and held it in 10 quarters.
Bay Harbor Wealth Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $99K in Q1 2022.
553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Bay Harbor Wealth Management's 13F filing for Q1 2023, filed 3 May 2023.